Figure 1 Principal pathogenic mechanisms of

Slides:



Advertisements
Similar presentations
Cytokine Responses to CPB Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.
Advertisements

Innate Immunity (part 1) BIOS 486A/586A
Chapter 14: Innate Immune System. Overview of Immune Defenses First-line defenses: – Intact, healthy skin and mucous membranes – Normal microbiota.
Biochemical Markers in the inflammatory response Dr Claire Bethune Consultant Immunologist Derriford Hospital.
October 12, IMMUNITY ADAPTIVEINNATE CELL MEDIATEDHUMORAL ANTIBODIES EFFECTOR SYSTEMS Fc Receptors Complement RECEPTORS EFFECTORS Cells Molecules.
Clare Dikken Macmillan Senior Chemotherapy Nurse Sussex Cancer Network
Topics Sensor systems Phagocytosis Inflammation Interferons Fever.
Awatif Jamal, MD, MSc, FRCPC, FIAC Consultant & Associate Professor Department of Pathology King Abdulaziz University Hospital.
Lecture # 39 HEMODYNAMICS - 7 Dr. Iram Sohail Assistant Professor Pathology College Of Medicine Majmaah University.
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Peter J. Barnes, FRS, FMedSci 
Innate Immune Response (Ch14)
Chapter 43 The Immune System.
Figure 2 Cell-mediated disease mechanisms of lupus nephritis
Figure 3 Neutrophils in liver inflammation
Figure 4 Interactions between adipose, the microbiome and kidney
Figure 1 Radiation-induced effects on tumour cells
Topics Sensor systems Phagocytosis Inflammation Interferons Fever.
Figure 5 Dendritic cells in liver inflammation
The inflammasome in liver disease
Figure 3 Proposed mechanisms underlying the links
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
The role of viruses in acute exacerbations of asthma
Peter J. Barnes, FRS, FMedSci 
Nat. Rev. Nephrol. doi: /nrneph
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
The Th17 immune response in renal inflammation
Volume 49, Issue 5, Pages (November 2008)
Volume 61, Issue 6, Pages (June 2002)
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Toll-like receptors in Borrelia burgdorferi-induced inflammation
Gut microbiota and non-alcoholic fatty liver disease: new insights
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Molecular mechanisms of crystal-induced necroinflammation
Roles for Chemokines in Liver Disease
Figure 4 Macrophage-targeting antitumour treatment approaches
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 The mechanism of injury in ACLF
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
Figure 2 Altered innate immune functions after sepsis
Figure 2 Emerging models of antibody-mediated rejection (ABMR) and
Figure 4 Macrophages in liver inflammation
Figure 3 Cascade of events leading from AKI to ALI
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 3 Pathological activation of complement
Figure 3 Biologics that attenuate effector responses in the kidney
The inflammatory response.
F.L. van de Veerdonk, B.-J. Kullberg, M.G. Netea 
Filtration function in glomerulonephritis
Figure 2 Mechanisms of crosstalk between adipocytes and the kidney
Figure 1 Sequence of events in the development of autoimmune nephritis
William G. Couser, Richard J. Johnson  Kidney International 
Volume 393, Issue 10174, Pages (March 2019)
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Volume 72, Issue 2, Pages (July 2007)
Macrophage heterogeneity in liver injury and fibrosis
Figure 2 Initiators of obesity-associated inflammation in adipocytes
Figure 4 Role of chemokines in dendritic cell migration
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Michael Karin, Toby Lawrence, Victor Nizet  Cell 
Volume 71, Issue 12, Pages (June 2007)
Endothelial cell activation
NODding off in acute kidney injury with progranulin?
Sachin P. Gadani, James T. Walsh, John R. Lukens, Jonathan Kipnis 
Peter J. Barnes, FRS, FMedSci 
Presentation transcript:

Figure 1 Principal pathogenic mechanisms of acute kidney injury in the context of sepsis or major surgery Figure 1 | Principal pathogenic mechanisms of acute kidney injury in the context of sepsis or major surgery. In both settings, alterations in systemic and glomerular haemodynamics — arising from the vasodilatory effects of systemic inflammatory mediators or anaesthesia, decreases in actual or effective in plasma volume and myocardial depression — may cause an early decrease in glomerular filtration rate (GFR) with potential for rapid reversibility (dotted arrows). Depending on the clinical context, these changes can be associated with high, normal or low cardiac output. However, both sepsis and tissue injury in surgery result in the generation of damage-associated molecular patterns (DAMPs) — including high mobility group protein B1 (HMGB1), histones, cell-free RNA and DNA, ribonuclear proteins, S100 proteins and heat-shock proteins — or pathogen-associated molecular patterns (PAMPs) — prototypically lipopolysaccharide but also including a vast array of other bacterial-specific or viral-specific molecules. These 'molecular patterns' are recognized by Toll-like receptors (TLRs), triggering systemic and local release of pro-inflammatory mediators, such as IL-1, IL-2, IL-6, IL-8 IL-12, IL-18, transforming growth factor-β (TGFβ), tumour necrosis factor (TNF), IFNγ, C-C chemokine ligand 2 (CCL2) and CCL5. Furthermore, antimicrobial drugs that are used for the treatment of infections can contribute to nephrotoxicity (Fig. 3). The effects of DAMPs and PAMPs are combined with those of specific immune responses and the generation of other inflammatory mediators, including products of coagulation and complement activation, leading to the recruitment of a peritubular inflammatory cell infiltrate (neutrophils, monocytes, macrophages and lymphocytes). Importantly, these circulating toxins and mediators may act directly on the endothelium or may be filtered in the glomerulus, where they interact with tubular cells and cause injury. The renal inflammatory response can cause injury to the endothelium, microcirculation and tubular cells. If this damage is severe, it will lead to sustained clinical acute kidney injury (AKI) that is unresponsive to the correction of systemic haemodynamic abnormalities. Finally, during critical illness, the effects of fluid overload, elevated venous pressure and development of abdominal compartment syndrome can also contribute to the persistence of AKI by an increase in tubular pressure and reduction of glomerular perfusion. Kellum, J. A. & Prowle, J. R. (2018) Paradigms of acute kidney injury in the intensive care setting Nat. Rev. Nephrol. doi:10.1038/nrneph.2017.184